Related Experiment Video
Updated: Sep 2, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
Published on: October 23, 2020
Risk of Sudden Death in a General Unbiased Epidemiological Cohort of Sarcoidosis
C Anwar A Chahal1,2,3,4, Peter A Brady1,5, Leslie T Cooper6
1Mayo Clinic College of Medicine and Science Mayo Clinic Rochester MN.
Insights
This study found no increased risk of sudden cardiac death (SCD) in people with sarcoidosis compared to the general population. While nocturnal deaths were more frequent in sarcoidosis patients, the difference was not statistically significant.
Area of Science:
- Cardiology
- Pulmonology
- Epidemiology
Background:
- Sarcoidosis is an inflammatory granulomatous disease of unknown etiology affecting multiple organ systems.
- Cardiovascular involvement in sarcoidosis is linked to increased risk of sudden cardiac death (SCD).
- The overall risk of SCD in the general sarcoidosis population remains unclear.
Purpose of the Study:
- To investigate and compare the risk of sudden cardiac death (SCD) in individuals diagnosed with sarcoidosis versus a matched general population.
- To analyze mortality patterns, including SCD, within a population-based cohort of sarcoidosis patients.
Main Methods:
- A population-based cohort study utilized data from January 1, 1976, to December 31, 2013.
- 345 incident sarcoidosis cases were age- and sex-matched with general population comparators.
- Mortality data, including cause and timing of death, were manually adjudicated for SCD events; Cox models were employed for comparisons.
Main Results:
- The incidence rate of SCD in the sarcoidosis cohort was 192 per 100,000 person-years, compared to 155 in the matched general population (Hazard Ratio [HR] 1.28, 95% CI 0.52-3.17).
- No statistically significant difference in SCD risk was observed between sarcoidosis patients and comparators.
- A higher frequency of nocturnal deaths was noted in the sarcoidosis group (HR 3.76), though this finding was not statistically significant.
Conclusions:
- This population-based study indicates that sarcoidosis does not confer an increased risk of sudden cardiac death compared to matched controls.
- Further research may be warranted to explore the observed trend of increased nocturnal deaths in sarcoidosis patients.
Abstract:
Background Sarcoidosis is an inflammatory, noncaseating, granulomatous disorder of unknown cause that can affect any body system and is associated with cardiovascular disease including sudden cardiac death (SCD). Cardiac involvement in sarcoidosis is associated with higher risk of SCD, but the SCD risk in the general sarcoidosis population is unknown. We aimed to determine the risk of SCD in people with sarcoidosis versus the matched general population. Methods and Results A population-based cohort of sarcoidosis and age- and sex-matched comparators from January 1, 1976 to December 31, 2013 was used; presence of other comorbidities in the comparator group was not an exclusion criterion. Mortality, including time, place, and cause of death were measured and manually adjudicated for SCD events. Incidence rates are reported per 100 000 person-years, and Cox models were used for group comparisons. Of the 345 incident cases of sarcoidosis (171 men; 50%) there were 58 reported deaths; 10 were definite/probable SCD versus 57 all-cause and 9 SCDs in comparators. Median follow-up was 12.9 years (interquartile range, 6.0-23.4 years) . Incidence rate of SCD in sarcoidosis was 192 (95% CI, 92-352) versus 155 (95% CI, 71-294) in comparators (hazard ratio [HR], 1.28 (95% CI, 0.52-3.17). Nocturnal deaths were more frequent in sarcoidosis 57 (95% CI, 12-168) versus 17 (95% CI, 0.4-95) (HR, 3.76 [95% CI, 0.39-36.47]). No significant differences were detected between the groups by sex, age, calendar year of diagnosis, or disease duration. Conclusions In a population-based cohort of patients with sarcoidosis, the risk for SCD compared with matched comparators was not increased. There were more nocturnal deaths among patients with sarcoidosis, yet this was statistically insignificant.
Related Concept Videos
Bias in Epidemiological Studies
Relative Risk
Confounding in Epidemiological Studies
Coronary Artery Disease III: Clinical Manifestations
Actuarial Approach
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Hazard Ratio
For example, in a clinical trial...

